|
VRCA Verrica Pharmaceuticals Inc 1660334 |
| Balance Sheet |
|
Current Assets
|
$32,639,000.00 |
|
Assets
|
$36,017,000.00 |
|
Current Liabilities
|
$22,442,000.00 |
|
Liabilities
|
$31,710,000.00 |
|
Equity
|
$4,307,000.00 |
|
Shares Out
|
17178786.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-18,441,000.00 |
| Market Analysis |
Market Cap
|
$83,488,899.96 |
|
Price
|
$4.86 |
|
BVPS
|
0.25 |
|
PB
|
19.44 |
|
EPS
|
-0.62 |
|
PS
|
1.64 |
|
FCF
|
$-18,441,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:51 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:41 |
|
| Apr |
May |
Jun |
| 2026-03-11 |
-0.51 |
|
|
2026-05-12 |
-0.41 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
0.25 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
0.13 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VRCA documents filed with the SEC.
VRCA Filings
Clear
